Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. HDOG HUB Message Board

$MNOV Company News Thursday’s top gaining an

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72748
Posted On: 09/16/2014 10:37:43 AM
Avatar
Posted By: Stock_Tracker
$MNOV Company News

Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
MediciNova dives on asthma study results 12:46 p.m. May 24, 2012 - Val Brickates Kennedy
H-P climbs, NetApp tumbles in after-hours trade 6:49 p.m. May 23, 2012 - Carla Mozee
MediciNova study doesn't yield significant results 5:10 p.m. May 23, 2012 - MarketWatch.com
Drug stocks move higher in late trading 3:26 p.m. March 24, 2011 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:37 p.m. Aug. 21, 2009 - MarketWatch
The Gap, J.M. Smucker, Ann Taylor in view 8:33 a.m. Aug. 21, 2009 - MarketWatch
MediciNova to acquire Avigen for $1.24 a share 6:17 a.m. Aug. 21, 2009 - William L. Watts
MediciNova to buy Avigen for $1.24/share 6:03 a.m. Aug. 21, 2009 - Steve Goldstein
Avigen holders would get net cash value plus $3M 6:13 a.m. June 25, 2009 - Simon Kennedy
MediciNova, Avigen agree terms of proposed deal 6:11 a.m. June 25, 2009 - Simon Kennedy
MediciNova reaches tentative deal to buy Avigen 6:10 a.m. June 25, 2009 - Steve Goldstein
MediciNova proposes to acquire Avigen 7:10 a.m. Dec. 23, 2008 - Aude Lagorce
MediciNova makes offer for Avigen 7:07 a.m. Dec. 23, 2008 - Aude Lagorce
MediciNova reports progress in asthma-drug Phase II trial 6:25 a.m. Sept. 9, 2008 - Robert Daniel
NediciNova reports positive preliminary Phase II results 6:09 a.m. Sept. 9, 2008 - Simon Kennedy
MediciNova withdraws plan for secondary stock offering 7:32 a.m. Nov. 8, 2007 - Mike Maynard
MediciNova pulls public offering of 6M shares 7:22 a.m. Nov. 8, 2007 - Aude Lagorce
MediciNova to focus on 2 drugs, to stop asthma drug trial 6:15 a.m. June 26, 2007 - Sarah Turner
MediciNova to focus on MN-221, MN-166 6:02 a.m. June 26, 2007 - Steve Goldstein


MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog 5:00 p.m. Aug. 28, 2014 - Zacks.com
MediciNova to start ALS trial 11:52 a.m. Aug. 26, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 4:02 p.m. Aug. 5, 2014 - TheStreet.com
3 Drugs Stocks Pushing The Industry Higher 4:02 p.m. July 30, 2014 - TheStreet.com
10-Q: MEDICINOVA INC 5:12 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
MediciNova: Gestation Is Slow And Uncomfortable - Birth Is Sudden And Unexpected 5:47 p.m. Feb. 25, 2014 - Seeking Alpha
MediciNova rallies on NASH study hopes 9:36 a.m. Jan. 14, 2014 - Seeking Alpha
MediciNova (MNOV) Jumps: Stock Adds 22.2% in Session - Tale of the Tape 9:51 a.m. Dec. 13, 2013 - Zacks.com
10-Q: MEDICINOVA INC 5:14 p.m. Aug. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
MediciNova Presents MN-166 Data - Analyst Blog 6:15 p.m. June 19, 2013 - Zacks.com
Stock Market Today: Big Winners & Losers for Wednesday 4:06 p.m. May 1, 2013 - 247WallSt.com
Biotech Movers: Affymax Crashes on Recall 3:40 a.m. March 4, 2013 - InvestorPlace.com
Secretive Dilution And A Possible Equity Financing From MediciNova 2:49 p.m. Feb. 27, 2013 - Seeking Alpha
4 Healthcare Stock Stories to Heal the Tuesday Blues 6:54 p.m. Feb. 26, 2013 - Wall St. Cheat Sheet
Positive Data on MediciNova's MN-221 - Analyst Blog 5:00 p.m. Aug. 24, 2012 - Zacks.com
3 Reasons This Speculative Bio-Pharma Is A Winner 5:22 p.m. Aug. 10, 2012 - Seeking Alpha
Must Know Stock Upgrades and Downgrades Today 2:51 p.m. May 24, 2012 - Wall St. Cheat Sheet
Signet Jewelers, MediciNova: Biggest Price Decliners (SIG, MNOV) 12:49 p.m. May 24, 2012 - The Wall Street Journal Interactive Edition
End Of Week Bio-Pharma Catalyst Trade And Watch List 7:55 a.m. May 4, 2012 - Seeking Alpha
Health Care Sector Wrap 4:48 p.m. May 3, 2012 - FOXBusiness


MediciNova Announces New NIDA Grant for MN-166 (ibudilast) in Opioid Dependence 7:01 p.m. Sept. 7, 2014 - GlobeNewswire
MediciNova to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF) 7:01 p.m. Sept. 1, 2014 - GlobeNewswire
MediciNova to Initiate Clinical Trial of MN-166 (ibudilast) in ALS 7:01 p.m. Aug. 25, 2014 - GlobeNewswire
MediciNova Announces Positive Interim Results of Phase 2a Study of MN-166 (ibudilast) in Opioid Dependence 7:00 p.m. Aug. 18, 2014 - GlobeNewswire
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Nonalcoholic Fatty Liver Disease 7:07 p.m. Aug. 11, 2014 - GlobeNewswire
Spasticity Global Clinical Trials Review, H2, 2014 4:42 p.m. Aug. 11, 2014 - PR Newswire - PRF
MediciNova Announces Positive Results of MN-001 in Advanced NASH Mouse Model; MediciNova Requests a Meeting With FDA 7:31 a.m. Aug. 5, 2014 - GlobeNewswire
MediciNova to Present Data on MN-001 for the Treatment of NASH (Nonalcoholic Steatohepatitis) During the JDDW 2014 (Japan Digestive Disease Week 2014) 7:00 p.m. July 7, 2014 - GlobeNewswire
MediciNova Announces Positive Results in Study of MN-001 in Mouse Model of Pulmonary Fibrosis 7:00 p.m. June 11, 2014 - GlobeNewswire
MediciNova Announces Management Appointment 7:01 p.m. April 8, 2014 - GlobeNewswire
MediciNova Appoints Yoshio Ishizaka to its Board of Directors 7:01 p.m. April 8, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 11:01 a.m. April 8, 2014 - ACCESSWIRE
MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S. 9:00 a.m. Jan. 14, 2014 - GlobeNewswire
MediciNova Receives New Patent Covering MN-221 in Irritable Bowel Syndrome 7:00 p.m. Nov. 11, 2013 - GlobeNewswire
MediciNova Reports Third Quarter 2013 Results 7:30 p.m. Nov. 7, 2013 - GlobeNewswire
MediciNova Appoints Yutaka Kobayashi to Its Board of Directors 5:00 p.m. Oct. 16, 2013 - GlobeNewswire
MediciNova Appoints Geoffrey O'Brien as Vice President 4:30 p.m. Oct. 16, 2013 - GlobeNewswire
MediciNova Receives Notice of Allowance for New Patent Covering MN-029 (denibulin) di-hydrochloride 7:00 p.m. Oct. 6, 2013 - GlobeNewswire
National Institute on Alcohol Abuse and Alcoholism Funds New UCLA Clinical Trial of MediciNova's MN-166 in Treating Alcoholism 7:00 p.m. Aug. 25, 2013 - GlobeNewswire
MediciNova Reports Second Quarter 2013 Results 5:30 p.m. Aug. 8, 2013 - GlobeNewswire



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us